<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04786665</url>
  </required_header>
  <id_info>
    <org_study_id>59650A</org_study_id>
    <nct_id>NCT04786665</nct_id>
  </id_info>
  <brief_title>Strawberries, Cognition, and Vascular Health</brief_title>
  <official_title>Impact of Strawberries on Cognition, and Vascular and Cardiometabolic Markers in Older Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Diego State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Diego State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to investigate the effects of strawberries on&#xD;
      cognitive responses, motor control function, and vascular and cardiometabolic risk markers in&#xD;
      healthy older adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To achieve the objectives, 40 healthy men and women â‰¥65 years of age will consume 26 g of&#xD;
      freeze-dried strawberries in the form of a drink-mix daily for 8 wk. Using a randomized&#xD;
      crossover study design, the effects will be compared to the effects of 8 wk intake of a&#xD;
      placebo drink-mix (with a 4 wk wash-out period between trials). Cognitive function&#xD;
      measurements will be performed at baseline and 8 wk. Additionally, at each timepoint,&#xD;
      flow-mediated vasodilation and blood pressure will be measured followed by collection of&#xD;
      fasting blood samples to assess glucose, insulin, blood lipids (free fatty acids,&#xD;
      triacylglycerol, total cholesterol, LDL cholesterol, and HDL cholesterol), inflammatory&#xD;
      markers (interleukins 6 and 18), and markers of oxidative stress (oxidized LDL-C and&#xD;
      malondialdehyde).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Using a randomized crossover study design, the effects will be compared to the effects of 8 wk intake of a placebo drink-mix (with a 4 wk wash-out period between trials).</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in processing speed (cognition) at 8 weeks</measure>
    <time_frame>At baseline, at 8 weeks</time_frame>
    <description>using Pattern Comparison Processing Speed Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in executive function (cognition) at 8 weeks</measure>
    <time_frame>At baseline, at 8 weeks</time_frame>
    <description>using Dimensional Change Card Sort Test; Flanker Inhibitory Control and Attention Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in working memory (cognition) at 8 weeks</measure>
    <time_frame>At baseline, at 8 weeks</time_frame>
    <description>using List Sorting Working Memory Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in episodic memory (cognition) at 8 weeks</measure>
    <time_frame>At baseline, at 8 weeks</time_frame>
    <description>using Picture Sequence Memory Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in working memory (cognition) at 8 weeks</measure>
    <time_frame>At baseline, at 8 weeks</time_frame>
    <description>using Picture Vocabulary Test; Oral Reading Recognition Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Vascular health at 8 weeks</measure>
    <time_frame>At baseline, at 8 weeks</time_frame>
    <description>to better understand how changes in the gut microbiota through fruit consumption are linked to changes in health outcomes, we will assess endothelial function via flow-mediated vasodilation and risk factors for cardiometabolic dysfunction in fasting blood samples collected at baseline and after 8 weeks.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Aging</condition>
  <condition>Healthy Aging</condition>
  <arm_group>
    <arm_group_label>Strawberry powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants consume 1 package of standard strawberry powder (26 g) daily for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants consume 1 package of placebo powder (26 g) daily for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Strawberry</intervention_name>
    <description>Freeze dried strawberry powder</description>
    <arm_group_label>Strawberry powder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo group</intervention_name>
    <description>Comparative placebo powder</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy men and women 65 years and older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  stroke or myocardial infarction&#xD;
&#xD;
          -  neurological disorders:&#xD;
&#xD;
          -  epilepsy,&#xD;
&#xD;
          -  multiple sclerosis,&#xD;
&#xD;
          -  Parkinson's disease,&#xD;
&#xD;
          -  stroke&#xD;
&#xD;
          -  known metabolic disorders:&#xD;
&#xD;
          -  liver,&#xD;
&#xD;
          -  renal&#xD;
&#xD;
          -  clinically diagnosed diabetes&#xD;
&#xD;
          -  drug treatment for lipid reduction or hypertension,&#xD;
&#xD;
          -  psychiatric medication use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shirin Hooshmand</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92182-7251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirin Hooshmand, PhD, RD</last_name>
      <phone>619-594-6984</phone>
      <email>shooshmand@sdsu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>March 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2021</study_first_posted>
  <last_update_submitted>March 5, 2021</last_update_submitted>
  <last_update_submitted_qc>March 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Diego State University</investigator_affiliation>
    <investigator_full_name>Shirin Hooshmand</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cognition</keyword>
  <keyword>Motor control</keyword>
  <keyword>Vascular health</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

